(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 0.5% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.02%.
Avanos Medical's revenue in 2025 is $699,900,000.On average, 3 Wall Street analysts forecast AVNS's revenue for 2025 to be $32,006,764,755, with the lowest AVNS revenue forecast at $30,751,597,509, and the highest AVNS revenue forecast at $32,948,140,189. On average, 3 Wall Street analysts forecast AVNS's revenue for 2026 to be $32,432,890,321, with the lowest AVNS revenue forecast at $31,161,012,269, and the highest AVNS revenue forecast at $33,386,798,860.
In 2027, AVNS is forecast to generate $33,995,350,731 in revenue, with the lowest revenue forecast at $32,662,199,721 and the highest revenue forecast at $34,995,213,987.